Nathaniel Bouganim
Overview
Explore the profile of Nathaniel Bouganim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
1730
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Spreafico A, Winquist E, Ho C, OSullivan B, Bouganim N, Chua N, et al.
Curr Oncol
. 2025 Jan;
32(1).
PMID: 39851964
Although the majority of patients with nasopharyngeal carcinoma (NPC) present with early-stage or locoregional disease that can be treated with definitive radiotherapy, approximately 20% of patients experience disease recurrence, and...
2.
Doyle C, Lohmann A, Iqbal N, Henning J, Kulkarni S, Califaretti N, et al.
Breast Cancer Res Treat
. 2025 Jan;
PMID: 39847203
Purpose: Understanding real-world treatment patterns and their effectiveness in HR + HER2- advanced breast cancer (aBC) in Canadian patients. Patient And Methods: This was a multi-center, observational, prospective cohort study...
3.
Sadeghi N, Subramaniam T, Richardson K, Mascarella M, Zeitouni A, Shenouda G, et al.
JAMA Otolaryngol Head Neck Surg
. 2024 Dec;
151(2):128-134.
PMID: 39636629
Importance: Distant metastasis (DM) remains the leading cause of death in patients treated for human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). An effective treatment strategy needs to address DM...
4.
Cao J, Surgeoner B, Manna M, Boileau J, Gelmon K, Brackstone M, et al.
Curr Oncol
. 2024 Nov;
31(11):7226-7243.
PMID: 39590163
The accurate staging of breast cancer is fundamental for guiding treatment decisions and predicting patient outcomes. However, there can be considerable variation in routine clinical practice based on individual interpretation...
5.
Manna M, Gelmon K, Boileau J, Brezden-Masley C, Cao J, Jerzak K, et al.
Curr Oncol
. 2024 Nov;
31(11):6536-6567.
PMID: 39590115
Human epidermal growth factor receptor 2-positive (HER2+) breast cancer is an aggressive subtype of breast cancer associated with a poor prognosis when sub-optimally treated. Recent advances include new and effective...
6.
Bian D, Cohen S, Lazaratos A, Bouganim N, Dankner M
Curr Oncol
. 2024 Oct;
31(10):6314-6342.
PMID: 39451775
Antibody-drug conjugates (ADCs) represent an emerging class of targeted anticancer agents that have demonstrated impressive efficacy in numerous cancer types. In non-small cell lung cancer (NSCLC), ADCs have become a...
7.
Mascarella M, Richardson K, Mlynarek A, Hier M, Caglar D, Florianova L, et al.
Otolaryngol Head Neck Surg
. 2024 Sep;
171(6):1773-1779.
PMID: 39342503
Objective: Limited progress has occurred in treating operable human papillomavirus (HPV)-negative head and neck squamous cell carcinoma (HNSCC). Accessing timely care remains challenging in public health care systems, potentially resulting...
8.
Mascarella M, Vendra V, Sultanem K, Tsien C, Shenouda G, Sridharan S, et al.
J Geriatr Oncol
. 2024 Sep;
15(8):102064.
PMID: 39271411
Introduction: Frailty is a recognized condition associated with poorer outcomes in patients with head and neck cancer (HNC). The objective of this study was to ascertain the prognostic significance of...
9.
Diaconescu A, Silver J, Subramaniam T, Sewitch M, Mascarella M, Ramirez-Garcia Luna J, et al.
J Otolaryngol Head Neck Surg
. 2024 Jun;
53:19160216241248670.
PMID: 38888957
Background: Patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with radiation-based therapy suffer from short- and long-term toxicities that affect quality of life (QOL). Transoral robotic surgery (TORS) has an...
10.
Kulkarni A, Hennessy C, Wilson G, Ramesh V, Hwang C, Awosika J, et al.
Clin Lung Cancer
. 2024 May;
25(5):e229-e237.e7.
PMID: 38744613
No abstract available.